Prevention of CV Disease with Statins 葉宏一 MD, PhD 馬偕醫學院 醫學系 教授兼主任 台北醫學大學 醫學科學研究所 兼任教授 馬偕紀念醫院 內科部
演講人:陳玉昆副教授 高雄醫學大學附設醫院口腔病理科主任 暨主治醫師...
-
Upload
caroline-daring -
Category
Documents
-
view
271 -
download
9
Transcript of 演講人:陳玉昆副教授 高雄醫學大學附設醫院口腔病理科主任 暨主治醫師...
演講人:陳玉昆副教授 高雄醫學大學附設醫院口腔病理科主任 暨主治醫師 日 期: 2010 年 12 月 24 日地 點:第一教學大樓 B1 演藝廳
Part I : Case report-Mandibular aneurysmal bone cystPart II : Case report-Pleomorphic adenoma with extensive necrosis Part II : Experimental study-Ameloblastoma
Content
Part I Chin Dent J 1990;19:33-41
Aneurysmal bone cyst of the mandible – a case report
Yuk-Kwan Chen, Li-Min Lin, Cheng-Chung Lin and Steven Lai
Chin Dent J 1990;19:33-41
Aneurysmal bone cyst of the mandible – a case report
Yuk-Kwan Chen, Li-Min Lin, Cheng-Chung Lin and Steven Lai
IHC: Factor VIII (-ve staining)
+internalcontrol
Citation: 3 times
Oral Diseases 2004;10:54-9
Part II
Expression of osteonectin/secreted protein acidic and rich in cysteine (SPARC) and matrix metalloproteinases (MMPs) in ameloblastoma
Shen, Ling-ChangChen, Yuk-KwanShaw, Shyh-Yu
Part III
Ameloblastoma/ 釉質母細胞瘤• Odontogenic epithelial origin
• The most common clinically significant odontogenic tumor (59.3%~63.2%)
• A locally aggressive neoplasm
• Surgery
• High recurrent rate (50-90%)
Contemporary oral and maxillofacial pathology 1997, 126-34Contemporary oral and maxillofacial pathology 1997, 126-34
SPARC
• Secreted Protein Acidic and Rich in Cysteine• Osteonectin/BM-40/43-kd protein• Bone-specific protein linking mineral to collagen
• Multifunctional glycoprotein (tissue differentiation, embryo
development) • Modulate cell-matrix interactions and cell function
• Re-appear in response to tissue injury, inflammation, and remodeling, as well as in tumor growth
and metastasis
Termine et al. Cell 1981;26:99-105, FASEB J 8:163-73, 1994, Matrix biology 2000;19:816-827Termine et al. Cell 1981;26:99-105, FASEB J 8:163-73, 1994, Matrix biology 2000;19:816-827
Tissue specific of SPARC in tumorsTumor enhancer Description
Glioma Enhances invasion (migration)
Melanoma Promotes metastasis (proliferation and migration)
Non small cell lung cancer Favors invasion and migration
Invasive meningiomas Diagnostic marker (negative in benign/non-invasive type)
Tumor suppressor Description
Ovary carcinoma Induces apoptosis
Pancreatic carcinoma Target for aberrant methylation
Breast cancer cells Inhibits proliferation (MDA-MB-231)
Neuroblastoma Inhibits angiogenesis
Role is not the same in different tumors
Int J Cancer: 2006;118,310-316. Journal of cellular biochemistry 2004;92:679-90Int J Cancer: 2006;118,310-316. Journal of cellular biochemistry 2004;92:679-90
Colorectal carcinoma Tumor-associated blood vessels
Matrix metalloproteinases (MMPs)• Six subfamilies • Zinc- and calcium-dependent enzymes that degrade native
and denatured collagen and other extracellular components <Extracellular matrix (ECM) turnover>• Rise rapidly when tissues undergo remodeling, such as in
inflammation, wound healing, and cancer
• Gelatinase, MMP-2 and -9, are essential proteases for basement membrane-invasive events (nonfibrillar collagen type IV)
Circ Res 2003; 92:827-39, modified Circ Res 2003; 92:827-39, modified
Invasion of the surrounding tissue
Gene Therapy 2006;13:464–77Gene Therapy 2006;13:464–77
MMPs
Angiogenesis switch
Matrix metalloproteinases (MMPs) in the invasiveness of ameloblastoma
Histopathology 2004;45:65–72Histopathology 2004;45:65–72
Bone Neoplasm
Bone
Bone Bone
Neoplasm
Neoplasm Neoplasm
(a)Mitogens
(b)Mitogens
MMPs
(1,2,9)(1,2,9)MMPs
(c)MMPs inducebone resorption andrelease of mitogensfrom the bone matrix
(d)Mitogens induce proliferationof ameloblastoma cellsas cords branching outfrom the central portionsof the neoplasm
SPARC and MMPs
• SPARC expression in human melanoma cells directly correlated with MMP-2 and MMP-9 levels and activity
• SPARC induces MMP-2 activation in human breast cancer cell line
• Both SPARC and MMP-9 have impact on ECM deposition and angiogenesis in the tumor microenvironment
Nature medicine 1997;3,171-5, , Cancer research 1998;58,5529-36,Experimental biology and medicine online April 29,2008
Nature medicine 1997;3,171-5, , Cancer research 1998;58,5529-36,Experimental biology and medicine online April 29,2008
AIMS
• To verify the pathologic expression of SPARC in ameloblastoma
• To establish the association between the presence of SPARC and MMPs in a cohort of ameloblastoma patients.
IHC expression of MMP-1, -2, -9 and SPARC
MMP-1MMP-1 MMP-2MMP-2
MMP-9MMP-9 SPARCSPARC
Immunohistochemical reactivity
• Immunoreactivity for SPARC, MMP-1, MMP-2 & MMP-9 was evaluated and classified into four groups:
score 0-2 (+)
score 3-5 (++)
score 6-8 (+++)
score 9-12 (++++)
• Pearson’s χ2-test. P -values less than 0.05 were considered to indicate statistical significance
Am J Pathol 1996;149,:1449-57, modifiedAm J Pathol 1996;149,:1449-57, modified
Case no. SPARC MMP-1 MMP-2 MMP-9
1* ++ ++ ++ +++
2 +++ ++ ++++ ++++
3 + ++ + ++
4* ++++ ++ ++ ++++
5* +++ ++ ++++ ++++
6 +++ ++ + +++
7* +++ ++ ++ ++++
8 +++ +++ +++ ++++
9 +++ ++ ++ ++++
10 ++ +++ ++ +++
11 ++++ +++ ++++ ++++
12 ++++ + + ++++
Case no. SPARC MMP-1 MMP-2 MMP-9
13 ++++ + ++ ++++
14 +++ + ++ ++++
15* ++ ++ ++ ++
16 +++ ++ + ++++
17 +++ + +++ ++++
18 ++++ +++ + ++++
19* ++++ + + ++++
20* +++ + ++ ++++
21 ++++ ++ +++ ++++
22 ++++ ++ ++ ++++
23 ++++ ++ ++ ++++
Immunohistochemical reactivity
1. 在 ameloblastoma tissue 當中,的確有 SPARC 的不正常表現2. 不同的 sample 之間,同一個蛋白質,有不同的表現強度;同一個 sample 的不同蛋白質,也有不同表現強度
SPARC MMP-1 MMP-2 MMP-9
SPARC 0.8122 0.5984 0.0003*
MMP-1 0.8122 0.8374 0.5062
MMP-2 0.5984 0.8374 0.8644
MMP-9 0.0003* 0.5062 0.8644
Associations between the immunoscores of SPARC, MMP-1, -2 and -9
IHC of MMP-9 and SPARC
MMP-9MMP-9 SPARCSPARC
Co-expression of SPARC and MMP-9 ( Double stain IHC)
MMP-9MMP-9 SPARCSPARC
Co- expressionCo- expression
A
B C
Conclusion I
• First to identify the pathologic expression of SPARC in ameloblastoma tissues
• SPARC was elevated consistently in matched MMP-9 expression
SPARC protein
MMP-9
VEGF
Angiogenesis
Expression in
Ameloblastoma
Tumor Invasion
Pinheiro et al, 2004
Kumamoto et al, 2002
Hei
ssig
et a
l, 20
02
Framson & Sage, 2004
Kato et al, 2001
J Oral Pathol Med 2010;39:242-9 J Oral Pathol Med 2010;39:242-9
Conclusion II :Putative association between SPARC and MMP-9 in ameloblastoma
Thank you very much